| Schedule of Earnings Per Share, Basic and Diluted |
The following table sets forth the computation of basic earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
Three Months Ended |
| (In thousands, except per share amounts) |
|
October 3, 2026 |
|
September 27, 2025 |
|
October 3, 2026 |
|
September 27, 2025 |
| Basic Earnings (Loss) per Common Share: |
|
|
|
|
|
|
|
|
| Net Income (Loss) - Basic |
|
$ |
112,804 |
|
|
$ |
(256) |
|
|
$ |
52,204 |
|
|
$ |
(11,098) |
|
| Weighted Average Shares - Basic |
|
42,967 |
|
|
42,447 |
|
|
43,014 |
|
|
42,507 |
|
| Basic Earnings (Loss) per Common Share |
|
$ |
2.63 |
|
|
$ |
(0.01) |
|
|
$ |
1.21 |
|
|
$ |
(0.26) |
|
The following table sets forth the computation of diluted net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
Three Months Ended |
| (In thousands, except per share amounts) |
|
October 3, 2026 |
|
September 27, 2025 |
|
October 3, 2026 |
|
September 27, 2025 |
| Diluted Earnings (Loss) per Common Share: |
|
|
|
|
|
|
|
|
| Net Income (Loss) - Basic |
|
$ |
112,804 |
|
|
$ |
(256) |
|
|
$ |
52,204 |
|
|
$ |
(11,098) |
|
| Convertible Notes Interest Expense, Net of Tax |
|
1,075 |
|
|
— |
|
|
358 |
|
|
— |
|
| Net Income (Loss) - Diluted |
|
$ |
113,879 |
|
|
$ |
(256) |
|
|
$ |
52,562 |
|
|
$ |
(11,098) |
|
|
|
|
|
|
|
|
|
|
| Weighted Average Shares - Basic |
|
42,967 |
|
|
42,447 |
|
|
43,014 |
|
|
42,507 |
|
| Net Effect of Dilutive Stock Awards |
|
1,810 |
|
|
— |
|
|
1,863 |
|
|
— |
|
| Net Effect of Dilutive Convertible Notes |
|
3,393 |
|
|
— |
|
|
3,654 |
|
|
— |
|
| Weighted Average Shares - Diluted |
|
48,170 |
|
|
42,447 |
|
|
48,531 |
|
|
42,507 |
|
|
|
|
|
|
|
|
|
|
| Diluted Earnings (Loss) per Common Share |
|
$ |
2.36 |
|
|
$ |
(0.01) |
|
|
$ |
1.08 |
|
|
$ |
(0.26) |
|
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Antidilutive shares excluded from diluted earnings per share computations as of the date indicated were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
Three Months Ended |
| (In thousands) |
|
October 3, 2026 |
|
September 27, 2025 |
|
October 3, 2026 |
|
September 27, 2025 |
| Stock Options and Unvested RSUs |
|
— |
|
|
1,423 |
|
|
— |
|
|
1,514 |
|
| 2030 Convertible Notes |
|
— |
|
|
8,335 |
|
|
— |
|
|
7,507 |
|
| Total Antidilutive Securities |
|
— |
|
|
9,758 |
|
|
— |
|
|
9,021 |
|
|